Effect of combined treatment with radiation and low dose etoposide on cell survival

Naoyuki Shigematsu, T. Kawata, N. Ihara, O. Kawaguchi, S. Kutsuki, R. Ishibashi, A. Kubo, H. Ito

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: To improve the radiotherapy results, we evaluated etoposide as an effective radiosensitizer by using cultured cell-lines. Materials and Methods: Four cell lines having different doubling times (DT) were used: V79 (Chinese hamster fibroblasts, DT=9 hours), (1), T24 (human bladder cancer, DT=19 hours) (2), MDA-MB231 (human breast cancer, DT=25-30 hours) (3) and RMG1 (human ovarian cancer, DT=50 hours) (4). Cell survival was determined by colony assay and cell cycle analysis was performed by flow-cytometry. Results; The survival curves showed RMG1 to be the most radiosensitive, followed by MDA-MB231, T24, and V79. V79 was most chemosensitive to etoposide, followed by T24, MDA-MB231 and RMG1. Neither 24-hours exposure to etoposide (≤0.05 μg/ml) or 0.5-h exposure (≤1.0 μg/ml) had any cell killing effect on any of the cell lines used. When the cells were irradiated after exposure to 1 μg/ml of etoposide for 0.5 hours, no radiosensitization was observed in any of the cell lines except V79. Enhanced radiosensitivity was observed in V79 and T24 cells (which have a relatively short DT) when they were incubated with 0.05 μg/ml etoposide for 24 hours but no enhanced effect was seen in MDA-MB231 or RMG1 cells (which have a relatively long DT). Conclusion: It is suggested that a combination of radiation and etoposide may be useful in the treatment of rapidly growing cancer.

Original languageEnglish
Pages (from-to)325-328
Number of pages4
JournalAnticancer Research
Volume21
Issue number1 A
Publication statusPublished - 2001

Fingerprint

Etoposide
Cell Survival
Radiation
Cell Line
Therapeutics
Radiation Tolerance
Cricetulus
Urinary Bladder Neoplasms
Ovarian Neoplasms
Cultured Cells
Cell Cycle
Flow Cytometry
Radiotherapy
Fibroblasts
Breast Neoplasms
Survival
Neoplasms

Keywords

  • Etoposide
  • Radiosensitization

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Shigematsu, N., Kawata, T., Ihara, N., Kawaguchi, O., Kutsuki, S., Ishibashi, R., ... Ito, H. (2001). Effect of combined treatment with radiation and low dose etoposide on cell survival. Anticancer Research, 21(1 A), 325-328.

Effect of combined treatment with radiation and low dose etoposide on cell survival. / Shigematsu, Naoyuki; Kawata, T.; Ihara, N.; Kawaguchi, O.; Kutsuki, S.; Ishibashi, R.; Kubo, A.; Ito, H.

In: Anticancer Research, Vol. 21, No. 1 A, 2001, p. 325-328.

Research output: Contribution to journalArticle

Shigematsu, N, Kawata, T, Ihara, N, Kawaguchi, O, Kutsuki, S, Ishibashi, R, Kubo, A & Ito, H 2001, 'Effect of combined treatment with radiation and low dose etoposide on cell survival', Anticancer Research, vol. 21, no. 1 A, pp. 325-328.
Shigematsu N, Kawata T, Ihara N, Kawaguchi O, Kutsuki S, Ishibashi R et al. Effect of combined treatment with radiation and low dose etoposide on cell survival. Anticancer Research. 2001;21(1 A):325-328.
Shigematsu, Naoyuki ; Kawata, T. ; Ihara, N. ; Kawaguchi, O. ; Kutsuki, S. ; Ishibashi, R. ; Kubo, A. ; Ito, H. / Effect of combined treatment with radiation and low dose etoposide on cell survival. In: Anticancer Research. 2001 ; Vol. 21, No. 1 A. pp. 325-328.
@article{660aa46df4ad4a6c821bd739d88f2992,
title = "Effect of combined treatment with radiation and low dose etoposide on cell survival",
abstract = "Background: To improve the radiotherapy results, we evaluated etoposide as an effective radiosensitizer by using cultured cell-lines. Materials and Methods: Four cell lines having different doubling times (DT) were used: V79 (Chinese hamster fibroblasts, DT=9 hours), (1), T24 (human bladder cancer, DT=19 hours) (2), MDA-MB231 (human breast cancer, DT=25-30 hours) (3) and RMG1 (human ovarian cancer, DT=50 hours) (4). Cell survival was determined by colony assay and cell cycle analysis was performed by flow-cytometry. Results; The survival curves showed RMG1 to be the most radiosensitive, followed by MDA-MB231, T24, and V79. V79 was most chemosensitive to etoposide, followed by T24, MDA-MB231 and RMG1. Neither 24-hours exposure to etoposide (≤0.05 μg/ml) or 0.5-h exposure (≤1.0 μg/ml) had any cell killing effect on any of the cell lines used. When the cells were irradiated after exposure to 1 μg/ml of etoposide for 0.5 hours, no radiosensitization was observed in any of the cell lines except V79. Enhanced radiosensitivity was observed in V79 and T24 cells (which have a relatively short DT) when they were incubated with 0.05 μg/ml etoposide for 24 hours but no enhanced effect was seen in MDA-MB231 or RMG1 cells (which have a relatively long DT). Conclusion: It is suggested that a combination of radiation and etoposide may be useful in the treatment of rapidly growing cancer.",
keywords = "Etoposide, Radiosensitization",
author = "Naoyuki Shigematsu and T. Kawata and N. Ihara and O. Kawaguchi and S. Kutsuki and R. Ishibashi and A. Kubo and H. Ito",
year = "2001",
language = "English",
volume = "21",
pages = "325--328",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1 A",

}

TY - JOUR

T1 - Effect of combined treatment with radiation and low dose etoposide on cell survival

AU - Shigematsu, Naoyuki

AU - Kawata, T.

AU - Ihara, N.

AU - Kawaguchi, O.

AU - Kutsuki, S.

AU - Ishibashi, R.

AU - Kubo, A.

AU - Ito, H.

PY - 2001

Y1 - 2001

N2 - Background: To improve the radiotherapy results, we evaluated etoposide as an effective radiosensitizer by using cultured cell-lines. Materials and Methods: Four cell lines having different doubling times (DT) were used: V79 (Chinese hamster fibroblasts, DT=9 hours), (1), T24 (human bladder cancer, DT=19 hours) (2), MDA-MB231 (human breast cancer, DT=25-30 hours) (3) and RMG1 (human ovarian cancer, DT=50 hours) (4). Cell survival was determined by colony assay and cell cycle analysis was performed by flow-cytometry. Results; The survival curves showed RMG1 to be the most radiosensitive, followed by MDA-MB231, T24, and V79. V79 was most chemosensitive to etoposide, followed by T24, MDA-MB231 and RMG1. Neither 24-hours exposure to etoposide (≤0.05 μg/ml) or 0.5-h exposure (≤1.0 μg/ml) had any cell killing effect on any of the cell lines used. When the cells were irradiated after exposure to 1 μg/ml of etoposide for 0.5 hours, no radiosensitization was observed in any of the cell lines except V79. Enhanced radiosensitivity was observed in V79 and T24 cells (which have a relatively short DT) when they were incubated with 0.05 μg/ml etoposide for 24 hours but no enhanced effect was seen in MDA-MB231 or RMG1 cells (which have a relatively long DT). Conclusion: It is suggested that a combination of radiation and etoposide may be useful in the treatment of rapidly growing cancer.

AB - Background: To improve the radiotherapy results, we evaluated etoposide as an effective radiosensitizer by using cultured cell-lines. Materials and Methods: Four cell lines having different doubling times (DT) were used: V79 (Chinese hamster fibroblasts, DT=9 hours), (1), T24 (human bladder cancer, DT=19 hours) (2), MDA-MB231 (human breast cancer, DT=25-30 hours) (3) and RMG1 (human ovarian cancer, DT=50 hours) (4). Cell survival was determined by colony assay and cell cycle analysis was performed by flow-cytometry. Results; The survival curves showed RMG1 to be the most radiosensitive, followed by MDA-MB231, T24, and V79. V79 was most chemosensitive to etoposide, followed by T24, MDA-MB231 and RMG1. Neither 24-hours exposure to etoposide (≤0.05 μg/ml) or 0.5-h exposure (≤1.0 μg/ml) had any cell killing effect on any of the cell lines used. When the cells were irradiated after exposure to 1 μg/ml of etoposide for 0.5 hours, no radiosensitization was observed in any of the cell lines except V79. Enhanced radiosensitivity was observed in V79 and T24 cells (which have a relatively short DT) when they were incubated with 0.05 μg/ml etoposide for 24 hours but no enhanced effect was seen in MDA-MB231 or RMG1 cells (which have a relatively long DT). Conclusion: It is suggested that a combination of radiation and etoposide may be useful in the treatment of rapidly growing cancer.

KW - Etoposide

KW - Radiosensitization

UR - http://www.scopus.com/inward/record.url?scp=0035060810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035060810&partnerID=8YFLogxK

M3 - Article

C2 - 11299757

AN - SCOPUS:0035060810

VL - 21

SP - 325

EP - 328

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1 A

ER -